-
1601
Montreal Cognitive Assessment and Modified Mini Mental State Examination in African Americans
Published 2015-01-01“…Five hundred and thirty African Americans with type 2 diabetes were enrolled in African American-Diabetes Heart Study-MIND, a cross-sectional study of cognition and structural and functional brain imaging. …”
Get full text
Article -
1602
Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy
Published 2025-02-01“…Methods This retrospective study enrolled 241 type 2 diabetic patients with biopsy-proven DN. Huaxi Emotional-Distress Index (HEI) was used to evaluate the depression and anxiety status of patients on admission. …”
Get full text
Article -
1603
Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Published 2025-01-01“…An important task for primary health care, where most patients with type 2 diabetes are diagnosed, treated, and followed, is to increase awareness and early detection of cognitive dysfunction in these patients for optimizing risk factor control.…”
Get full text
Article -
1604
Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy
Published 2019-01-01“…Diabetic nephropathy (DN) is a serious kidney-related complication of type 1 and type 2 diabetes. The Chinese herbal formula Baoshenfang (BSF) shows therapeutic potential in attenuating oxidative stress and apoptosis in podocytes in DN. …”
Get full text
Article -
1605
Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
Published 2024-12-01“…Furthermore, end-stage kidney disease severely affects life expectancy and quality of life. Type 2 diabetes and hypertension are not only primary causes of CKD but also independent risk factors for CVD, which underscores the importance of effective treatment strategies for these conditions. …”
Get full text
Article -
1606
Changes in Glucose Metabolism and Atherogenic Risk Factors in Diabetic Patients’ First-degree Relatives
Published 2023-05-01“…<br /><strong>Method:</strong> a descriptive cross-sectional study was carried out between January 2020 and January 2022, which included first-degree relatives of type 2 diabetic patients, dispensed at medical office No. 10 belonging to the Héroes del Moncada University Policlinic from the Plaza de la Revolución municipality, 122 patients older than 19 years old were studied. …”
Get full text
Article -
1607
Cardiovascular Profile and Cardiovascular Imaging After Bariatric Surgery: A Narrative Review
Published 2025-01-01“…<i>Materials and Methods</i>: The patients eligible for BaS commonly suffer from multiple chronic conditions, including type 2 diabetes, obstructive sleep apnea, cardiovascular diseases, and non-alcoholic fatty liver disease. …”
Get full text
Article -
1608
Antioxidant and Antihyperglycemic Properties of Three Banana Cultivars (Musa spp.)
Published 2016-01-01“…The low sugar, GI, amylose, and amylopectin contents of the three banana cultivars as well as their α-amylase and α-glucosidase inhibitory activities could be possible mechanisms and justification for their recommendation in the management of type-2 diabetes.…”
Get full text
Article -
1609
Hyperglycemia Does Not Affect Iron Mediated Toxicity of Cultured Endothelial and Renal Tubular Epithelial Cells: Influence of L-Carnosine
Published 2016-01-01“…Iron has been suggested to affect the clinical course of type 2 diabetes (T2DM) as accompanying increased intracellular iron accumulation may provide an alternative source for reactive oxygen species (ROS). …”
Get full text
Article -
1610
Adaptation of the nutrition care process for metabolic diseases in the Mexican population
Published 2025-01-01“…A team of registered dietitians from two tier 3 hospitals, each with over five years of experience in metabolic disease management, customized the NCP’s four core steps—assessment, diagnosis, intervention, and monitoring—to meet the specific needs of the Mexican population.ResultsWe adapted the NCP to manage five common metabolic disorders: obesity, type 2 diabetes, kidney disease, metabolic dysfunction-associated steatotic liver disease, and dyslipidemia. …”
Get full text
Article -
1611
Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial
Published 2015-01-01“…We analyzed sex differences in pharmacotherapy strategies and attainment of goals for hemoglobin A1c (HbA1c), blood pressure (BP), and low density lipoprotein cholesterol (LDL-C) in patients with type 2 diabetes and established coronary artery disease enrolled into the BARI 2D trial. …”
Get full text
Article -
1612
Foxtail millet supplementation improves glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin-induced diabetes
Published 2022-01-01“…Our findings provide further support that consuming more whole-grain FM might be beneficial to individuals suffering from type 2 diabetes.…”
Get full text
Article -
1613
Ginsenoside F1 administration promotes UCP1-dependent fat browning and ameliorates obesity-associated insulin resistance
Published 2023-11-01“…Obesity-induced type 2 diabetes is mainly due to excessive free fatty acids leading to insulin resistance. …”
Get full text
Article -
1614
Association of sildenafil use with age-related macular degeneration: a retrospective cohort study
Published 2024-04-01“…The study found no significant difference in AMD incidence between the sildenafil users and the non-users, with an adjusted hazard ratio (HR) of 0.99 (95% CI 0.84 to 1.16), after accounting for confounders such as age, ethnicity, Townsend deprivation quintile, body mass index category, and diagnosis of hypertension and type 2 diabetes.Conclusion The study results indicated no significant association between sildenafil use and AMD prevention in UK men with erectile dysfunction, suggesting sildenafil’s protective effect on AMD is likely insignificant.…”
Get full text
Article -
1615
Semaphorin3B Promotes Proliferation and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in a High-Glucose Microenvironment
Published 2021-01-01“…However, high-glucose (HG) conditions in type 2 diabetes mellitus (T2DM) exert deleterious effects on BMSC proliferation and osteogenic differentiation. …”
Get full text
Article -
1616
Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
Published 2017-01-01“…We collected specimens and evaluated clinicopathological parameters of 102 stage I to III CRC patients with prediagnosed type 2 diabetes mellitus (DM II). Expression of E-cadherin and vimentin in tumors was detected by immunohistochemistry (IHC), and statistical analysis was performed using SPSS 19.0. …”
Get full text
Article -
1617
The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol.
Published 2025-01-01“…<h4>Background</h4>People with severe mental illness (SMI) are more likely to develop long-term physical health conditions, including type 2 diabetes and cardiovascular disease, compared to people without SMI. …”
Get full text
Article -
1618
Appendicitis After Initiation of Tirzepatide
Published 2025-01-01“…Garrett Chan1, Mariam Ansar1, Marlena Klein1,21Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA; 2Cooper Medical School of Rowan University, Camden, New Jersey, USACorrespondence: Garrett Chan, Email chan-garrett@cooperhealth.eduAbstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss. Common side effects of Tirzepatide include nausea, vomiting, and diarrhea. …”
Get full text
Article -
1619
Predicting high sensitivity C-reactive protein levels and their associations in a large population using decision tree and linear regression
Published 2024-12-01“…Except for fasting blood glucose (FBG), hypertension (HTN), and Type 2 diabetes mellites (T2DM), all variables showed significant differences between the two groups. …”
Get full text
Article -
1620
The impact of creatine supplementation on the development of kidney disease – literature review
Published 2025-02-01“…State of knowledge: Research supports creatine’s efficacy in improving athletic performance, recovery, and muscle strength, with therapeutic benefits in neurodegenerative diseases, type 2 diabetes, aging, and chronic conditions. Robust trials show no adverse renal effects in healthy individuals, even with long-term or high-dose use. …”
Get full text
Article